Richmond, VA 的 胰臟癌 臨床試驗
7 項針對 胰臟癌 的研究正在 Richmond(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
正在為研究招募對象嗎?將此頁面置頂展示 — $99 / 30 天 →
The Vanguard Study: Testing a New Way to Screen for Cancer
招募中歡迎健康志工
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
招募中觀察性研究
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
招募中1/2 期
- VCU Massey Comprehensive Cancer Center, Richmond
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
招募中3 期
- Bon Secours Saint Mary's Hospital, Richmond
- Bon Secours Cancer Institute at Reynolds Crossing, Richmond
- Bon Secours Memorial Regional Medical Center, Mechanicsville · 距離 6 英里
- 還有 1 項
Pancreatic Cancer Early Detection Consortium
招募中觀察性研究歡迎健康志工
- VCU Massey Comprehensive Cancer Center, Richmond
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
招募中3 期
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
招募中2 期
- Ohio State University-Telemedicine, Richmond
其他城市的 胰臟癌 試驗
- Houston, TX61 項研究
- New York City, NY60 項研究
- Boston, MA43 項研究
- Nashville, TN39 項研究
- Los Angeles, CA35 項研究
- St. Louis, MO33 項研究
- Arlington, VA33 項研究
- Baltimore, MD31 項研究
- San Antonio, TX31 項研究
- Philadelphia, PA26 項研究
- Tampa, FL26 項研究
- Durham, NC24 項研究
Richmond 的其他研究
- 乳癌26 項研究
- 非小細胞肺癌25 項研究
- 前列腺癌19 項研究
- 心臟衰竭16 項研究
- 肺癌14 項研究
- 心血管疾病13 項研究
- 大腸直腸癌13 項研究
- 脂肪性肝病12 項研究
- 急性髓系白血病12 項研究
- 轉移性癌症12 項研究
- 頭頸部鱗狀細胞癌12 項研究
- 黑色素瘤11 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月6日。各研究自行設定資格標準;由研究團隊決定參與者資格。